The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer

Abstract

Obesity is not associated with more aggressive clinicopathological features of thyroid cancer. Obesity is not a risk factor for progression to more advanced stages of disease, nor is it a prognostic factor for poorer treatment response and clinical outcome.